Long-term treatment strategies in major depression: A 2-year prospective naturalistic follow-up after successful electroconvulsive therapy

Journal of ECT

Volumn 28, Issue 2, 2012, Pages 92-97

  Martínez Amorós, Erika ^a,b   Cardoner, Narcís ^a,c   Soria, Virginia ^a   Gálvez, Verònica ^a   Menchón, José Manuel ^a,c   Urretavizcaya, Mikel ^a,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

continuation; electroconvulsive therapy; maintenance; major depressive disorder; recurrence; relapse

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CITALOPRAM; CLOMIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LITHIUM; METHYLPHENIDATE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SERTRALINE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; DEVICES; DISEASE DURATION; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; HAMILTON SCALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; RELAPSE; REMISSION; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION;

AGED; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LONG-TERM CARE; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84861822854     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31823e2705     Document Type: Article

References (35)

1. Abrams R. Electroconvulsive Therapy. 2nd ed. New York, NY: Oxford University Press; 1992.
2. Fink M, Abrams R, Bailine S, et al. Ambulatory electroconvulsive therapy: report of a task force of the Association for Convulsive Therapy. Convuls Ther. 1996;12:42-55.
3. Grunhaus L, Pande AC, Haskett RF. Full and abbreviated courses of maintenance electroconvulsive therapy. Convuls Ther. 1990;6:130-138.
4. Sackeim HA, Prudic J, Devenand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10:96-104.
5. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. A randomized controlled trial. JAMA. 2001;285(10):1299-1307.
6. Bourgon LN, Kellner CH. Relapse of depression after ECT: a review. J ECT. 2000;16:19-31.
7. Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004;55:301-312.
8. Tew JD, Benoit BH, Haskett RF, et al. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry. 2007;19(1):1-4.
9. Aronson TA, Shukla S, Hoff A. Continuation therapy after ECT for delusional depression: a naturalistic study of prophylactic treatments and relapse. Convuls Ther. 1987;3:251-259.
10. O'Leary DA, Lee AS. Seven-year prognosis in depression mortality and readmission risk in the Nottingham ECT cohort. Br J Psychiatry. 1996;169:423-429.
11. Winokur G, Coryell W, Keller M, et al. Relationship of electroconvulsive therapy to course in affective illness: a collaborative study. Eur Arch Psychiatry Clin Neurosci. 1990;240:54-59.
12. Malcolm K, Dean J, Rowlands P, et al. Antidepressant drug treatment in relation to use of ECT. J Psychopharmacol. 1991;5:255-258.
13. van Beusekom BS, van den Broek WW, Birkenhäger TK. Long-term follow-up after successful electroconvulsive therapy for depression: a 4-to 8-year naturalistic follow-up study. J ECT. 2007;23: 17-20.
14. A Task Force Report of the American Association. The Practice of Electroconvulsive Therapy Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association 2001.
15. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs. pharmacotherapy for relapse prevention in major depression. A multisite study from the CORE (Consortium for Research in ECT). Arch Gen Psychiatry. 2006;63:1337-1344.
16. Srinivasan TN, Suresh TR, Jayaram V. Issues in the use of maintenance electroconvulsive therapy. Indian J Psychiatry. 1995;37:139-142.
17. Fox HA. Extended continuation and maintenance ECT for long-lasting episodes of major depression. J ECT. 2001:17(1):60-64.
18. Andrade C, Kurinji MB. Continuation and maintenance ECT: a review of recent research. J ECT. 2002;18(3):149-158.
19. Aziz M, Mehringer AM, Mozurkewich E, et al. Cost-utility of 2 maintenance treatments for older adults with depression who responded to a course of electroconvulsive therapy: results for a decision analytic model. Can J Psychiatry. 2005;50:389-397.
20. Thase M, Rush A. Treatment resistant depression. In: Bloom FEKD, ed. Psychopharmacology: The Fourth Generation of Progress. NY: Raven Press; 1995:1081-1097.
21. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58(suppl 13):23-29.
22. Petrides G, Fink M. The "half-age" stimulation strategy for ECT dosing. Convuls Ther. 1996;12:138-146.
23. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry. 1991;48:851-855.
24. Grunhaus L, Dolberg O, Lustig M. Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation. J Psychiatr Res. 1995;29(3):165-172.
25. Birkenhäger TK, Renes JW, Pluijms EM. One-year follow-up after successful ECT: a naturalistic study in depressed inpatients. J Clin Psychiatry. 2004;65:87-91.
26. van den Broek WW, Birkenhäger TK, Mulder PG, et al. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry. 2006;67: 263-268.
27. Russell JC, Rasmussen KG, O'Connor MK, et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT. 2003;19:4-9.
28. Schwarz T, Loewenstein J, Isenberg KE. Maintenance ECT: indications and outcome. Convuls Ther. 1995;11:14-23.
29. Vanelle JM, Loo H, Galinowski A, et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther. 1994;10(3):195-205.
30. Swoboda E, Conca A, König P, et al. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology. 2001;43:23-28.
31. Gupta S, Tobiansky R, Bassett P, et al. Efficacy of maintenance electroconvulsive therapy in recurrent depression: a naturalistic study. J ECT. 2008;24:191-194.
32. O'Connor DW, Gardner B, Presnell I, et al. The effectiveness of continuation-maintenance ECT in reducing depressed older patients' hospital re-admissions. J Affect Disord. 2010;120:62-66.
33. Gagné GG, Furman MJ, Carpenter LL, et al. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressant alone in depressed patients. Am J Psychiatry. 2000;157:1960-1965.
34. Petrides G, Dhossche D, Fink M, et al. Continuation ECT: relapse prevention in affective disorders. Convuls Ther. 1994;10:189-194
35. Spiker DG, Stein J, Rich CL. Delusional depression and electroconvulsive therapy: one year later. Convuls Ther. 1985;1:167-172.